Fourth, the Commission established that there are sufficient alternative sources of supply. The Union has a significant trade surplus with the rest of the world in the medical device sector, estimated at over EUR 19 billion in 2023 [Source: Eurostat (https://ec.europa.eu/eurostat/web/main/home).], which suggests that exports could be redirected to the Union market in response to a potentially reduced supply of Chinese medical devices. Furthermore, the volume of medical devices affected by the IPI measure could also be replaced by either increased production of medical devices in the Union or increased volume of imports from other third countries, such as the United Kingdom, Switzerland, the United States and Japan [According to the latest Eurostat trade statistics on the sourcing of medical devices, the Union has imported EUR 49 billion of medical devices from third countries other than the PRC as indicated in recital 40.].
39 2. DETERMINATION OF THE IPI MEASURE › 2.2. Availability of alternative sources of supply, Regulation (EU) 2025/1197
In forcesince 19 Jun 2025